Lexaria Bioscience terminates $5M equity distribution agreement with JonesTrading

Lexaria Bioscience Corp.

Terminated Capital on Demand Sales Agreement with JonesTrading effective September 19, 2025.
Agreement allowed up to $5M in common stock; only 14,995 shares sold for $38,236 gross proceeds.
Original agreement dated Aug 21, 2024; amended Feb 5, 2025.

item 1.02

Lexaria Bioscience Corp. filing history →

Source: SEC EDGAR

accession 0001640334-25-001717

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.